Caution advised over psychedelic therapies
Research on incorporation of substances such as LSD in treatment of mental illness is in its infancy, experts say
Psychedelic therapies might benefit certain patients with mental illness, but research to date is insufficient to inform clinical practice, leading psychiatrists say.
In a clinical memorandum on the therapeutic use of psychedelic substances, the Royal Australian and New Zealand College of Psychiatrists has cautioned the evidence for their effectiveness and safety is limited.
